Genitourinary & Reproductive
The urinary tract, bladder and prostate, male and female sexual health, contraception, menstrual and gynaecological disorders, obstetric pharmacology, fertility, and genitourinary cancers.
The Urinary Tract as a Drug Target
Autonomic control of the bladder and urethra, urinary tract infections, and renal colic and stones.
Overactive Bladder & Incontinence
Antimuscarinics, beta-3 agonists and botulinum for overactive bladder, and stress incontinence, nocturia and enuresis.
Benign Prostatic Hyperplasia
Alpha-blockers, 5-alpha-reductase inhibitors, combination therapy and acute urinary retention.
Erectile Dysfunction & Male Health
PDE5 inhibitors, second-line therapies and priapism, and testosterone and male sexual health.
Contraception
Combined hormonal contraception, progestogen-only and long-acting methods, and emergency contraception.
Menstrual & Gynaecological Disorders
Heavy menstrual bleeding, endometriosis and fibroids, polycystic ovary syndrome, and menopause and HRT.
Obstetric Pharmacology
Labour induction and uterotonics, tocolytics and preterm labour, postpartum haemorrhage, and hypertension in pregnancy.
Fertility, STIs & Special Topics
Ovulation induction and assisted reproduction, sexually transmitted infections, prostatitis, and prescribing in pregnancy and renal impairment.
Genitourinary & Reproductive Cancers
Prostate cancer and androgen deprivation, bladder and kidney cancer therapy, and gynaecological and testicular cancers.
The Lower Urinary Tract as a Drug Target: Storing and Voiding
Almost every drug used for the bladder and the prostate makes sense only against one simple picture: the lower urinary tract spends its life doing two opposite jobs — quietly storing urine, then decisively emptying it. Each job is run by a different branch of the autonomic nervous system pressing on a different muscle through a different receptor. Learn that one control diagram and the whole pharmacology falls out of it: which receptor to block to calm an overactive bladder, which to block to open an obstructed outlet, which nerve to reinforce to hold urine in. Get the map right and you never memorise these drugs again — you derive them.
Urinary Tract Infections: Choosing and Timing the Antibiotic
A urinary tract infection is the commonest reason a healthy adult is handed an antibiotic — and one of the best places to learn how antibiotics are actually chosen. The right drug isn't the strongest one; it's the one that concentrates where the bug is, spares the ones that don't need treating, and fits the patient in front of you: pregnant or not, kidneys working or failing, first attack or fifth this year. Get those questions right and a UTI is three days and done. Get them wrong and you breed resistance, miss a pyelonephritis, or poison a fetus.
Renal Colic and Urinary Stones: Pain, Passage and Prevention
People who have felt renal colic and then given birth will tell you the stone was worse. A crystal a few millimetres wide, wedged in the ureter, can drop a grown adult to the floor. Yet the pharmacology of stones is not really about the crystal at all — it is about three separate jobs. Kill the pain now. Coax the stone out. And then, quietly and for years, change the chemistry of the urine so the next one never forms. Each job has its own drugs, and the third one depends entirely on what the stone is made of.
Overactive Bladder: Antimuscarinics and the Anticholinergic Burden
An overactive bladder is a bladder that will not wait. It squeezes when it should be filling quietly, and the patient is dragged to the toilet by an urgency they cannot argue with — day and night. The drugs that calm it are among the oldest and most reliable in urology, and they work by a beautifully simple idea: turn down the nerve signal that tells the bladder muscle to contract. But the same signal runs the salivary glands, the gut, the pupil and — crucially — the brain. So the story of these drugs is really the story of a trade-off: quieter bladder, drier mouth, foggier mind. Getting that balance right, especially in older patients, is the whole clinical craft.
Beta-3 Agonists and Botulinum Toxin: Beyond Antimuscarinics
The classic drug for an overactive bladder is an antimuscarinic — but for the very patients who need it most, the elderly with fragile memories and slow bowels, the anticholinergic price can be worse than the leaking. So pharmacology built two escape routes. One relaxes the same muscle by a completely different receptor, dodging every anticholinergic side effect. The other is a paralysing toxin injected straight into the bladder wall to switch off the muscle chemically. Knowing when to reach past the antimuscarinic — and what each alternative costs — is the whole clinical craft here.

